Literature DB >> 21981696

Implementation and external validation of Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score for predicting complications in 74 consecutive partial nephrectomies.

Stavros I Tyritzis1, Stefanos Papadoukakis, Ioannis Katafigiotis, Ioannis Adamakis, Ioannis Anastasiou, Konstantinos G Stravodimos, Christos Alamanis, Dionisios Mitropoulos, Constantinos A Constantinides.   

Abstract

UNLABELLED: Study Type - Prognosis (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Partial nephrectomy (PN) is the gold standard operation for small renal tumours. The decision for or against a PN has been based mostly on preoperative radiological evaluation of the tumour. Three nephrometry scoring systems have been recently proposed for prediction of postoperative complications of PN (RENAL, C-index and PADUA). We validate externally the accuracy of the PADUA system and suggest for the first time a novel scoring system, based on the original PADUA system, which implements three other significant factors for the postoperative course of a partial.
OBJECTIVE: • To externally validate the Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) classification of renal tumours managed by partial nephrectomy (PN). PATIENTS AND METHODS: • Seventy-four consecutive patients in a single academic tertiary institution underwent open PN. • Incidence of 90-day complications was stratified by several clinicopathological variables, such as gender, age of the patient, hospital stay, pathology report, tumour characteristics and positive surgical margins. PADUA scores were given to each case. • The severity of complications was also categorized with the Clavien system.
RESULTS: • The optimal threshold of PADUA for the prediction of complications was 8 with a sensitivity equal to 90.9% and a specificity equal to 77.8% (area under the curve [AUC], 0.89; 95% confidence interval [CI], 0.73-1.00). • Multivariate analysis revealed that that PADUA is an independent predictor for the risk of complications. • Also, PADUA score ≥ 8 identified a group of patients with almost 20-fold higher risk of complications (hazard ratio [HR]= 19.82; 95% CI, 1.79-28.35; P= 0.015). • Patients with papillary histology had greater risk for complications than those with clear-cell tumours (HR = 4.88; 95% CI, 1.34-17.76; P= 0.016).
CONCLUSIONS: • The PADUA score is a simple anatomical system that predicts the risk of postoperative complications. This is the first external validation of this system for open PN from a single centre. • The authors believe that PADUA is an efficient tool, since the only variable of the present study that predicted a higher incidence of complications was the histology type, which is determined after surgery. • However, it should be applied to laparoscopic and robot-assisted series and it could also include the ischaemia time and surgeon experience in the overall scoring to be complete.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21981696     DOI: 10.1111/j.1464-410X.2011.10644.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

Review 1.  [When is cytoreductive nephrectomy not beneficial for patients with metastatic renal cell carcinoma?]

Authors:  Martin Schostak
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

2.  The application of PADUA scoring system for predicting complications of laparoscopic renal cryoablation.

Authors:  Junlong Zhuang; Huibo Lian; Xiaozhi Zhao; Gutian Zhang; Weidong Gan; Xiaogong Li; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2015-03-18       Impact factor: 2.370

3.  Critical evaluation of the PADUA score in a retrospective analysis of open partial nephrectomy.

Authors:  Desiree Louise Draeger; Karl-Dietrich Sievert; Oliver W Hakenberg
Journal:  Turk J Urol       Date:  2018-03-16

Review 4.  A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Authors:  Tobias Klatte; Vincenzo Ficarra; Christian Gratzke; Jihad Kaouk; Alexander Kutikov; Veronica Macchi; Alexandre Mottrie; Francesco Porpiglia; James Porter; Craig G Rogers; Paul Russo; R Houston Thompson; Robert G Uzzo; Christopher G Wood; Inderbir S Gill
Journal:  Eur Urol       Date:  2015-04-22       Impact factor: 20.096

5.  Zonal NephRo Score: external validation for predicting complications after open partial nephrectomy.

Authors:  M C Kriegmair; P Mandel; A Moses; C Bolenz; M S Michel; D Pfalzgraf
Journal:  World J Urol       Date:  2015-08-01       Impact factor: 4.226

6.  Tumour-related imaging parameters predicting the percentage of preserved normal renal parenchyma following nephron sparing surgery: a retrospective study.

Authors:  Michael Aertsen; Frederik De Keyzer; Hendrik Van Poppel; Steven Joniau; Liesbeth De Wever; Evelyne Lerut; Raymond Oyen; Filip Claus
Journal:  Eur Radiol       Date:  2012-07-16       Impact factor: 5.315

7.  Perioperative morbidity and mortality of octogenarians treated by radical cystectomy-a multi-institutional retrospective study in Japan.

Authors:  Takashige Abe; Norikata Takada; Hiroshi Kikuchi; Ryuji Matsumoto; Takahiro Osawa; Sachiyo Murai; Naoto Miyajima; Satoru Maruyama; Nobuo Shinohara
Journal:  Jpn J Clin Oncol       Date:  2017-08-01       Impact factor: 3.019

8.  The association between the anatomical features of renal tumours and the functional outcomes of robot-assisted partial nephrectomy.

Authors:  Jeong Woo Lee; Sung Yong Cho; Chanhoo Jeon; Kyungtae Ko; Hyeon Hoe Kim
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

9.  Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.

Authors:  Hui Zhu; Haoyan Chen; Zhiqian Lin; Guohai Shi; Xiaozhu Lin; Zhiyuan Wu; Xia Zhang; Xi Zhang
Journal:  Oncotarget       Date:  2016-03-01

10.  Ubiquitin specific peptidase 21 regulates interleukin-8 expression, stem-cell like property of human renal cell carcinoma.

Authors:  Liang Peng; Yi Hu; Demeng Chen; Shunchang Jiao; Shengkun Sun
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.